Latest Als News

Belararox Limited has validated the presence of a copper porphyry system at its Malambo prospect in Argentina through recent geophysical surveys, setting the stage for an imminent drilling campaign.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

Great Dirt Resources Ltd. has confirmed significant manganese mineralisation at its Junior Prospect in NSW, revealing promising high-grade zones and multiple stacked lodes that could substantially boost the project's resource potential.

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Icetana AI has launched a fully underwritten renounceable entitlement offer to raise approximately A$2.65 million, aiming to bolster sales, marketing, and product development. The company is also nearing a potential $1.77 million deal linked to its Baghdad Safe City project in Iraq.

Nico Resources Limited reports steady progress on its flagship Wingellina nickel-cobalt project, highlighted by successful metallurgical testwork and Major Project Status recognition, despite cautious spending amid weak market conditions.

Gullewa Limited reports significant gold assay results from its 2024 Phase 1 drilling campaigns at the South Darlot Gold Project and British King, expanding known mineralisation zones and confirming high-grade potential.

The Australian Takeovers Panel has declared unacceptable circumstances in Alara Resources Limited's recent rights issue, citing inadequate disclosure and potential control issues involving Al Tasnim Infrastructure LLC. The company faces a costs order and must reassess its fundraising approach.

Asian Battery Metals has released final assay results from its 2024 Phase 2 drilling at the Oval Cu-Ni-PGE project in Mongolia, confirming multiple high-grade massive sulphide intercepts that underscore the prospect's potential.